Results 11 to 20 of about 36,449 (150)
ANTIHYPERTENSIVE EFFICACY OF VERAPAMIL PLUS INDAPAMIDE IN PATIENTS WITH METABOLIC SYNDROME [PDF]
Рациональная фармакотерапия в кардиологии, 2016 Aim. To study effect of combination of verapamil retard (Isoptinum SR) with indapamide retard (Arifon retard) on blood pressure (BP) level as well as lipid profile, glucose and electrolytes serum level in patients with metabolic syndrome (MS).Material ...
E. M. Idrisova +3 more
doaj +2 more sources
Comparative analysis of antihypertensive effects of chlorthalidone and indapamide-retard in combination with azilsartan medoxomil in patients with arterial hypertension [PDF]
Российский кардиологический журнал, 2019 Achievement of target blood pressure (BP) is one of the key strategies of primary prevention of cardiovascular complications in patients with arterial hypertension (AH). Aim.
Zh. D. Kobalava +3 more
doaj +2 more sources
Indapamide retard as the medication of choice in elderly patients with arterial hypertension [PDF]
Российский кардиологический журнал, 2013 The modern society faces a steady increase in the numbers of elderly people, which is associated with a range of social and medical problems. Age-related aspects of body anatomy and physiology, multiple comorbidity, and cognitive decline restrict the ...
I. I. Chukaeva, Ya. G. Spiryakina
doaj +2 more sources
Indapamide retard in complex therapy of patients with chronic heart failure and arterial hypertension [PDF]
Кардиоваскулярная терапия и профилактика, 2010 Aim. To investigate indapamide retard effects on clinico-laboratory parameters and clinical course in patients with Functional Class (FC) II-IV chronic heart failure (CHF) and arterial hypertension (AH). Material and methods.
S. N. Tereshchenko +4 more
doaj +1 more source
Long-term indapamide retard therapy in adolescents with Stage I arterial hypertension [PDF]
Кардиоваскулярная терапия и профилактика, 2011 Aim. To study the dynamics of office blood pressure (BP) levels, autonomic balance, endothelial dysfunction, and vascular remodelling in adolescents with Stage I arterial hypertension (AH), treated with indapamide retard (IR). Material and methods.
I. V. Logacheva, E. A. Gunicheva
doaj +2 more sources
Российский кардиологический журнал, 2018 The article presents data about the prevalence and expected prognosis for arterial hypertension. Emphasis is placed on the selection of antihypertensive therapy in elderly patients.
z. M. Galeyeva +4 more
doaj +2 more sources
Российский кардиологический журнал, 2008 The combination of verapamil retard and enalapril, or verapamil retard and indapamide SR similarly and significantly increased high-density lipoprotein cholesterol and stable NO2 metabolite levels, reducing platelet aggregation in patients with metabolic
N. M. Krasnova +10 more
doaj +1 more source
ORIGINAL Programme: study background and design [PDF]
Кардиоваскулярная терапия и профилактика, 2010 The paper presents the design of the ORIGINAL Programme (substituting indapamide generics with arifon retard in patients with arterial hypertension), evaluating blood pressure (BP) reduction in arterial hypertension (AH) patients starting the treatment ...
Yu. A. Karpov
doaj +1 more source
Therapeutic and biopharmaceutical assessment of indapamide medications [PDF]
Кардиоваскулярная терапия и профилактика, 1970 The paper is focussed on the drug release comparison for multisource indapamide medications against the original medication, Arifon retard (1,5 mg; Servier Laboratories, France).
G. V. Ramenskaya +4 more
doaj +1 more source
Diuretics in patients with metabolic disturbances
Кардиоваскулярная терапия и профилактика, 2007 Aim. To study antihypertensive effectiveness of indapamide retard, its effects on carbohydrate, lipid, purine, electrolyte metabolism in patients with mild arterial hypertension (AH) and metabolic syndrome (MS). Material and methods.
I. E. Chazova, V. B. Mychka
doaj +1 more source